RE:RE:RE:RE:Why the delay?
@ NMG good post, agree with that scenario as one very valid optionality, and there are others all being positive catalysts for investors of SNN. If you look at Canadian companies with plus 1 billion market caps, whom market caps are rationalized by international market penetration advancements for example. The theory is they will dominate the globe with first mover advantage, but it is more likely they are simply a stop gap to supply medicinal cannabis until these countries get their legislation and industrial complexes in line to supply their own populations. If companies such as Aphria,HEXO, had the opportunity to plop a 90,000 kg, pharmaceutical grade facility, complete with extraction facilities in a fully legalized 36,000,000 population jurisdiction and was the first to do it, I suspect their market caps would go through the roof. This would be first mover advantage, at scale, with domestic cultivation and full integration and a market begging for clean, high grade product. Well, this is where Sunniva now sits with their facility now complete and onboarding imminent. The automated facility with individual climate controlled bays can accomodate beverages, white label for FDA approved drugs, high end craft products, etc. Now with a market cap of 180 million, tightest share structure in the industry, and the Canadian market in capitulation mode near term, do your due diligence and consider how this plays out